TRex Bio, Inc. Common stock (TRXB) FinancialsTRXBTRex Bio, Inc. Common stock

In the context of the broader market, TRXB competes directly with industry leaders such as RZLT and AVTX. With a market capitalization of $396.04M, it holds a significant position in the sector. When comparing efficiency, TRXB's gross margin of N/A stands against RZLT's N/A and AVTX's N/A. Such benchmarking helps identify whether TRex Bio, Inc. is trading at a premium or discount relative to its financial performance.

The financial metrics show a P/E ratio of 0 and a forward P/E of 0, suggesting no earnings expectations. The EV to EBITDA is negative at -8.61, indicating potential issues with profitability.